The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; none of the 65 sources its claims cite is checked for support yet.
A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation
Open accessAbstract
Optic neuropathies, including glaucoma, are characterized by the progressive degeneration of retinal ganglion cells (RGCs), ultimately leading to irreversible vision loss. Increasing evidence implicates microglia, the resident immune cells of the central nervous system, as key modulators of RGC health and disease progression. However, the precise mechanisms by which microglia influence RGCs remain poorly understood, particularly in the human context. In this study, we established human pluripotent stem cell-derived coculture systems incorporating microglia, astrocytes, and RGCs to explore how microglia shape RGC growth and maturation under physiological conditions. We first examined the impact of homeostatic microglia on RGCs in both coculture and triculture systems, revealing distinct influences of cell types in coculture compared to when they were grown individually. We then modeled inflammatory states by activating microglia with lipopolysaccharide and evaluated their effects on RGCs both directly and in the context of astrocyte coculture. This stepwise, reductionist approach enabled us to dissect the cellular interactions driving RGC vulnerability in inflammatory conditions relevant to optic neuropathies. Our findings provide insight into the complex neuroimmune landscape that underlies RGC degeneration and identify key pathways that may serve as therapeutic targets across a range of optic nerve diseases.
Overview
CoChat Summary
TL;DR
The authors developed hPSC-derived co- and tri-culture systems of microglia, astrocytes, and retinal ganglion cells (RGCs) to model homeostatic and LPS-induced neuroinflammatory interactions. They report that homeostatic microglia enhance RGC maturation, whereas LPS-activated microglia, especially with astrocytes, drive RGC degeneration and pro-inflammatory transcriptional programs.
Key findings
- hPSC-derived microglia co-cultured with RGCs for 3 weeks enhanced RGC morphology—increased soma size, neurite length, and neurite complexity by Sholl analysis—and increased electrophysiological activity by multielectrode array, including mean firing rate and burst frequency, compared with RGCs alone.
- In tri-culture (RGC:microglia:astrocyte 5:1:2) for 1 week, all three cell types showed enhanced morphological maturation versus monoculture; scRNA-seq showed tri-culture RGCs upregulated maturation markers (NEFL, RBPMS, SYN1) and axonal growth/excitability genes, while monoculture RGCs expressed higher developmental genes (VSX2, RAX, ATOH7, SIX6).
- LPS (150 ng/ml, 24 h) activated hPSC-derived microglia, increasing MHC-II/CD74 expression, pro-inflammatory cytokine secretion by MSD V-Plex, and phagocytosis of pHrodo Zymosan-Red at all time points; LPS-activated microglia co-cultured with RGCs for 3 weeks reduced RGC soma size, neurite length, primary neurite number, mean firing rate, and burst frequency/percentage.
- In tri-culture with LPS every 48 h, RGC viability decreased at 1 week and further at 3 weeks, with retracted RGC morphology, reactive astrocytes (increased soma area, reduced branch length), and amoeboid microglia; scRNA-seq showed pro-inflammatory upregulation of RGC neuroinflammation/stress genes (CCL2, ADAM17, SPP1, SQSTM1, CTSD, TIGAR), astrocyte inflammatory/complement genes (CXCL10, CCL3, CXCL1, C1QA/C1QC/C1R), and microglial inflammatory/complement genes, while control microglia expressed homeostatic markers (P2RY12, CX3CR1, INPP5D, CSF1R).
Methods
- hPSC lines WTC-11 and H7 were differentiated into microglia-like cells via hematopoietic progenitors, astrocytes via a neural progenitor protocol, and RGCs from Brn3b-tdTomato-Thy1.2 retinal organoids followed by MACS sorting against Thy1.2.
- Co-cultures used RGC:microglia at 5:1; tri-cultures used RGC:microglia:astrocyte at 5:1:2. Microglia were activated with LPS (150 ng/ml) for 24 h or every 48 h for sustained activation; assays included immunocytochemistry, qRT-PCR, MSD V-Plex proinflammatory panel, pHrodo Zymosan phagocytosis, multielectrode array, and scRNA-seq (10x Chromium/NovaSeq 6000; GEO accession GSE308054).
- Statistics used Student’s t-test or one-way ANOVA with Tukey post-hoc at p < 0.05; scRNA-seq differential expression used the Wilcoxon rank-sum test with p < 0.05.
Limitations
- Stated in the paper: the 2D co-/tri-culture systems do not fully recapitulate the in vivo retinal microenvironment; future 3D microphysiological systems such as retinal organoids and microfluidic platforms are needed.
- Stated in the paper: cellular ratios were selected from prior studies to support survival and reproducible crosstalk, not to replicate in vivo abundance; a single native ratio is difficult to define because glial abundance differs between retina and optic nerve head/optic nerve. Current limitations also included loss of RGCs prior to functional maturation in organoids and reduced control over cell number, timing, and cell-type ratios, necessitating 2D platforms.
- Stated in the paper: LPS was used as a standard pro-inflammatory stimulus, but comprehensive comparison of activation paradigms was beyond scope; TNFα activation was only proof-of-concept. The OPTN(E50K) mutation did not produce significantly greater degeneration than control RGCs in the presence of LPS-stimulated microglia, likely because the robust neurotoxic effect of activated microglia masked additional vulnerability. Evident from the text: the study relies on in vitro morphological, functional, and scRNA-seq readouts without in vivo validation or direct mechanistic perturbation of the identified pathways.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 31 Not checked · 67 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Successful differentiation was then further confirmed via immunocytochemistry, which demonstrated robust expression of microglia-specific markers IBA1, P2RY12, and TREM2 in nearly all differentiated cells (Figure 1C–E).”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Microglia Enhance Retinal Ganglion Cell Morphological Complexity and Functional Maturation
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we observed that LPS-activated pro-inflammatory microglia reduced the mean firing rate of RGCs compared to controls (Figure 5H–J).”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Pro-inflammatory microglia promote RGC neurodegenerative phenotypes
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“when co-cultured with microglia for 1 week, hPSC-derived astrocytes exhibited more complex morphological features characterized primarily by increased branch length (Figure 2B–D).”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Establishment of a Tri-culture Model to Investigate Cellular Interactions Between Retinal Ganglion Cells, Astrocytes, and Microglia
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“monoculture microglia expressed higher levels of genes associated with neurodegenerative disease (BIN1, TREM2, SORL1, APOE)”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Single Cell RNA-seq profiling of RGCs, microglia, and astrocytes to identify transcriptional correlates of cellular maturation in tri-culture
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“qRT-PCR analyses demonstrated that LPS-activated MGLs also increased expression of the MHC-II transporter CD74 (Figure 4E), further supporting the ability to induce this activated microglial state (34).”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Stimulating a pro-inflammatory signature in microglia to explore neuroinflammatory phenotypes
What the sources say
- Not checked yetcites [34] Su H, Na N, Zhang X, Zhao Y, The biological function and significance of CD74 in immune diseases. Inflamm Res 66, 209– 216 (2017). 27752708 source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
54 more claims
Create a free account to see all 99 claims and to verify the 56 references still open.
- It may state two separate claims as one. 26
- The quote only partly states this claim. 1
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Use of the tri-culture model to investigate interactions between RGCs, astrocytes, and microglia under neuroinflammatory conditions
“At 1 week, LPS-treated cultures showed a significant reduction in RGC viability, with fewer MAP2+ RGCs per field of view”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Single Cell RNA-seq profiling of RGCs, microglia, and astrocytes to identify transcriptional correlates underlying neuroinflammatory signatures in tri-culture
“This timepoint was selected to capture early degenerative changes prior to significant RGC loss observed at later stages (Figure 6J–N).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Stimulating a pro-inflammatory signature in microglia to explore neuroinflammatory phenotypes
“microglia activated with TNFα in isolation and subsequently transferred on transwell inserts to cultures of RGCs”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > DISCUSSION
“TNFα-activated microglia conditioned medium transferred to RGC cultures was also sufficient to induce pathological RGC neurite phenotypes”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Conserved cell types with divergent features in human versus mouse cortex
Hodge, R. D., Bakken, T. E., Miller, J. A., Smith, K. A., Barkan, E. R., Graybuck, L. T., Close, J. L., Long, B., Johansen, N., Penn, O., et al. (2019) · Nature · doi:10.1038/s41586-019-1506-7 · Cited by 1,775
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution
Masuda, T., Sankowski, R., Staszewski, O., Böttcher, C., Amann, L., Sagar, Scheiwe, C., Nessler, S., Kunz, P., van Loo, G., et al. (2019) · Nature · doi:10.1038/s41586-019-0924-x · Cited by 1,310
iPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154
Microglial Phagocytosis of Live Neurons
Brown, G. C., & Neher, J. J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3710 · Cited by 853
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation
Jha, M. K., Jo, M., Kim, J.-H., & Suk, K. (2019) · The Neuroscientist · doi:10.1177/1073858418783959 · Cited by 579
Research works printed but not linked: 1
- J. Harkin Data from “A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation” NCBI Gene Expression Omnibus. Available at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308054. Deposited 15 September 2025. · doi:10.1101/2025.07.01.662573
Cited by
Generation of xenobiotic free retinofugal assembloids
Hayes, M., Michel, M. F. V., Kuehn, M. H., Kardon, R. H., & Gramlich, O. W. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1746709 · Cited by 3
Salkar, A., Palanivel, V., Basavarajappa, D. K., Heng, B., Schulz, A. M., Gupta, V. K., Graham, S. L., Mirzaei, M., & You, Y. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01905 · Cited by 2
Neuroinflammation in glaucoma: a myriad of cellular pathways and players
MacLean, M., Lydon, S. D., Gomes, C., Pizzi, E. M., Diemler, C. A., Yablonski, S. E. R., Howell, G. R., Meyer, J. S., & Libby, R. T. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10253-0 · Cited by 1
Self-citation
Metadata
- Authors
- Harkin, J., Gomes, C., Afify, R., Patil, S. V., Hetzer, S. M., Tutrow, K. D., Peña, K. H., Baker, A., Lavekar, S. S., Huang, K.-C., & Meyer, J. S.
- Affiliations
- Indiana University Indianapolis (US)
- Corresponding author
- Meyer, Jason S.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2026-08-19
- Volume
- 123
- Issue
- 34
- Pages
- e2522958123-e2522958123
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC13506028
- OpenAlex
- W4412024286
- Cited by
- 3
- References
- 72
- Citations by year
- 2026: 3
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- PubMed (submittedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Funders
- HHS | NIH | National Eye Institute (R01EY033022, U24EY033269)
- Gilbert Family Foundation (923016)
- BrightFocus Foundation (G2020369, G2022003F)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- retinal ganglion cells, microglia, neuroinflammation, optic neuropathy, glaucoma, human pluripotent stem cells, triculture, astrocytes, lipopolysaccharide, microglial activation, neuroimmune interactions, optic nerve diseases
- MeSH terms
- Neuroinflammatory Diseases, Astrocytes, Humans, Inflammation, Lipopolysaccharides, Retinal Ganglion Cells, Microglia, Coculture Techniques, Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation. https://app.cochat.ai/papers/10.1073/pnas.2522958123
- The paper
- Harkin, J., Gomes, C., Afify, R., Patil, S. V., Hetzer, S. M., Tutrow, K. D., Peña, K. H., Baker, A., Lavekar, S. S., Huang, K.-C., & Meyer, J. S. (2026). A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2522958123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.